These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29858981)

  • 1. Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives.
    Liu MZ; He HY; Luo JQ; He FZ; Chen ZR; Liu YP; Xiang DX; Zhou HH; Zhang W
    Arch Pharm Res; 2018 Jul; 41(7):725-736. PubMed ID: 29858981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Hyperglycaemia and Diabetes.
    Fathallah N; Slim R; Larif S; Hmouda H; Ben Salem C
    Drug Saf; 2015 Dec; 38(12):1153-68. PubMed ID: 26370106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs and hyperglycemia: A practical guide.
    Jain V; Patel RK; Kapadia Z; Galiveeti S; Banerji M; Hope L
    Maturitas; 2017 Oct; 104():80-83. PubMed ID: 28923179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotic drug use and diabetes.
    Ananth J; Venkatesh R; Burgoyne K; Gunatilake S
    Psychother Psychosom; 2002; 71(5):244-54. PubMed ID: 12207104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Care map. 2: Atypical antipsychotics. Diabetes and hyperglycaemia.
    Houltram B; Scanlan M
    Nurs Stand; 2004 Jun 2-8; 18(38):41-2. PubMed ID: 15199709
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.
    Della-Morte D; Palmirotta R; Rehni AK; Pastore D; Capuani B; Pacifici F; De Marchis ML; Dave KR; Bellia A; Fogliame G; Ferroni P; Donadel G; Cacciatore F; Abete P; Dong C; Pileggi A; Roselli M; Ricordi C; Sbraccia P; Guadagni F; Rundek T; Lauro D
    Pharmacogenomics; 2014 Dec; 15(16):2063-82. PubMed ID: 25521362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era: the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension, diabetes mellitus and hyperlipidemia) may be a reasonable strategy.
    de Leon J; Diaz FJ
    Schizophr Res; 2007 Nov; 96(1-3):185-97. PubMed ID: 17618085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
    Manolopoulos VG; Ragia G; Tavridou A
    Pharmacogenomics; 2011 Aug; 12(8):1161-91. PubMed ID: 21843065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced new onset diabetes in hypertension: does it matter?
    Nilsson PM
    J Hypertens; 2007 Jun; 25(6):1201-4. PubMed ID: 17563532
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes: Is There a Future for Pharmacogenomics Guided Treatment?
    Pearson ER
    Clin Pharmacol Ther; 2019 Aug; 106(2):329-337. PubMed ID: 31012484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetogenic effect of drugs].
    Vasilenko VV; Solomatin AS
    Sov Med; 1986; (4):50-4. PubMed ID: 3520872
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with antipsychotics and the risk of diabetes in clinical practice.
    Kessing LV; Thomsen AF; Mogensen UB; Andersen PK
    Br J Psychiatry; 2010 Oct; 197(4):266-71. PubMed ID: 20884948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus associated with atypical anti-psychotic medications.
    Clark C; Burge MR
    Diabetes Technol Ther; 2003; 5(4):669-83. PubMed ID: 14511422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics and diabetic propensity: more questions than answers?
    Dinan TG; Kohen D
    Hum Psychopharmacol; 2003 Dec; 18(8):591-3. PubMed ID: 14696017
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms.
    Buchholz S; Morrow AF; Coleman PL
    Intern Med J; 2008 Jul; 38(7):602-6. PubMed ID: 18715305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs, diabetes and pharmacogenomics: the road to personalized therapy.
    Watanabe RM
    Pharmacogenomics; 2011 May; 12(5):699-701. PubMed ID: 21619432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.